These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 13039951)

  • 21. [THE FIBRINOLYTIC THERAPY OF EXPERIMENTAL MASSIVE PULMONARY EMBOLISM IN RABBITS].
    MATTIOLI G; RABITTI G; NAVA C
    Minerva Cardioangiol; 1964 Jan; 12():25-8. PubMed ID: 14130219
    [No Abstract]   [Full Text] [Related]  

  • 22. Prothrombin and haemorrhage.
    DONALD AC; HUNTER RB; TUDHOPE GR; WALKER W; WHITTON I
    Br Med J; 1954 Oct; 2(4894):961-3. PubMed ID: 13199356
    [No Abstract]   [Full Text] [Related]  

  • 23. [METHOD OF SIMULTANEOUS DETERMINATION OF FIBRINOLYSIS AND FIBRINOGENOLYSIS].
    GRIBAUSKAS PS
    Lab Delo; 1964; 10():3-5. PubMed ID: 14138437
    [No Abstract]   [Full Text] [Related]  

  • 24. The comparative action of dicumarol and of phenylindanedione on the coagulase reacting factor and on prothrombin.
    TAGER M
    Yale J Biol Med; 1953 Apr; 25(5):374-82. PubMed ID: 13057268
    [No Abstract]   [Full Text] [Related]  

  • 25. THE EFFECT OF ATROMID ON PLASMA FIBRINOGEN AND HEPARIN RESISTANCE.
    COTTON RC; WADE EG; SPILLER GW
    J Atheroscler Res; 1963; 3():648-52. PubMed ID: 14100908
    [No Abstract]   [Full Text] [Related]  

  • 26. [Dynamics of fibrinogen, prothrombin and prothrombin time in labor and after labor].
    KISIN SV; KUZNETSOVA VI; TRETIAK GS
    Pediatr Akus Ginekol; 1962; 1():54-5. PubMed ID: 14456430
    [No Abstract]   [Full Text] [Related]  

  • 27. The influence of ACTH on prothrombin-proconvertin values in blood during treatment with dicumarol and phenylindanedione.
    HELLEM AJ; SOLEM JH
    Acta Med Scand; 1954; 150(5):389-93. PubMed ID: 13217736
    [No Abstract]   [Full Text] [Related]  

  • 28. The blood coagulation mechanism with especial reference to the prothrombin-proconvertin contents of plasma during long-term ACTH or cortisone therapy.
    FISCHER F; LUND E
    Acta Med Scand; 1954; 149(3):179-85. PubMed ID: 13180225
    [No Abstract]   [Full Text] [Related]  

  • 29. COUMARIN THERAPY. PROTHROMBIN ACTIVITY AFTER TERMINATION OF TREATMENT.
    REILLY EB; GOODMAN JR; WARNER GF
    Calif Med; 1963 Oct; 99(4):234-5. PubMed ID: 14051485
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [CONGENITAL AFIBRINOGENEMIA: A REPORT OF 4 CASES].
    DELAGE JM; BARRY A
    Can Med Assoc J; 1964 May; 90(22):1270-3. PubMed ID: 14158960
    [No Abstract]   [Full Text] [Related]  

  • 31. [Experiment on the effect of intramuscular injections and peroral application of fibrinogen solution produced from bovine blood on the prothrombin time determination in man].
    ESSER A; SCHOLL O; SCHMITZ L
    Z Gesamte Inn Med; 1951 Dec; 6(23-24):763-5. PubMed ID: 14932023
    [No Abstract]   [Full Text] [Related]  

  • 32. Clinical evaluation of three anticoagulants in thrombo-embolic disease.
    NEILSON JM; MOLLISON AW
    Br Med J; 1957 May; 1(5029):1214-7. PubMed ID: 13426587
    [No Abstract]   [Full Text] [Related]  

  • 33. Control of anticoagulant therapy. A comparison of the thrombotest, the prothrombin-proconvertin method, and the prothrombin time.
    FICHERA C
    Acta Med Scand; 1962 Sep; 172():363-7. PubMed ID: 13945019
    [No Abstract]   [Full Text] [Related]  

  • 34. [Heparin tolerance test and prothrombin time in the control of anticoagulant therapy of coronary infarction].
    HOLLER G; WEINMANN O; HAMMERL H; ZEMANN J
    Wien Klin Wochenschr; 1953 May; 65(20):402-4. PubMed ID: 13078388
    [No Abstract]   [Full Text] [Related]  

  • 35. [Effect of heparin and protamine on fibrinogen precipitation].
    TARNOKY K
    Kiserl Orvostud; 1961 Dec; 13():633-40. PubMed ID: 13919689
    [No Abstract]   [Full Text] [Related]  

  • 36. [COAGULATION AND ANTICOAGULATION SYSTEM OF THE BLOOD AND ITS REACTION TO CORONARY CIRCULATION DISORDERS].
    IAROSHEVSKII AIa; ZHAVORONKOVA EK
    Ter Arkh; 1964 Jan; 36():36-42. PubMed ID: 14149441
    [No Abstract]   [Full Text] [Related]  

  • 37. Control of dicumarol therapy by means of a micromethod for the quantitative determination of plasma prothrombin and proconvertin.
    LUND E; DYGGVE H
    Acta Med Scand; 1954; 150(4):271-5. PubMed ID: 13217722
    [No Abstract]   [Full Text] [Related]  

  • 38. [Tromexan and marcoumar in anticoagulant therapy; micromethod for determination of prothrombin-proconvertin activity].
    IVERSEN T
    Ugeskr Laeger; 1955 Jul; 117(27):873-8. PubMed ID: 13256759
    [No Abstract]   [Full Text] [Related]  

  • 39. [METHOD OFSTUDY OF BLOOD COAGULATION BASED ON THE CHANGES IN ELECTRIC RESISTANCE OF THE FIBRINNETWORK].
    BAYOBAYO JM; ZULUAGAJARAMILLO E
    Arch Inst Farmacol Exp (Madr); 1963; 15():75-93. PubMed ID: 14049389
    [No Abstract]   [Full Text] [Related]  

  • 40. PROBLEMS IN HEMOSTASIS WITH EXTRACORPOREAL APPARATUS.
    GIBBON JH; CAMISHION RC
    Ann N Y Acad Sci; 1964 Jul; 115():195-8. PubMed ID: 14192824
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.